Results for: R&D

Activist investor Starboard Value has sharply criticized Pfizer, accusing the pharmaceutical giant of failing to deliver on its promises of innovation and growth. Starboard argues that Pfizer’s leadership has not capitalized on the momentum following the COVID-19 pandemic, resulting in underperformance in research and development (R&D) and mergers and acquisitions (M&A). The investor highlights the company’s missed targets, inflated acquisitions, and lagging returns on investments, calling for the board to hold management accountable.

Nintendo’s record-breaking R&D spending in Fiscal Year 2024 suggests the company is heavily invested in the development of a new Switch console, likely the rumored Switch 2. This investment includes research into deep learning, hinting at the potential use of NVIDIA’s DLSS technology for 4K gaming on the new console.

Nokia refuted reports of selling its mobile-networks business, stating it is committed to its success. The company also announced the expansion of its Fixed Networks R&D facility in Chennai, India, demonstrating its commitment to the country and global technological advancements.